Literature DB >> 27776571

Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.

C Shah1, W Zhang2, Y Xiao2, L Yao2, Y Zhao2, X Gao2, L Liu2, J Liu2, S Li2, B Tao2, Z Yan1, Y Fu1, Q Gong2, S Lui1.   

Abstract

Studies of schizophrenia at drug-naive state and on antipsychotic medication have reported a number of regions of gray-matter (GM) abnormalities but the reports have been inconsistent. The aim of this study was to conduct multimodal meta-analysis to compare the cross-sectional voxel-based morphometry studies of brain GM in antipsychotic-naive first-episode schizophrenia (AN-FES) and those with antipsychotic treatment within 1 year (AT-FES) to determine the similarities and differences in these groups. We conducted two separate meta-analyses containing 24 studies with a sample size of 801 patients and 957 healthy controls. A multimodal meta-analysis method was used to compare the findings between AN-FES and AT-FES. Meta-regression analyses were done to determine the influence of different variables including age, duration of illness, and positive and negative symptom scores. Finally, jack-knife analyses were done to test the robustness of the results. AN-FES and AT-FES showed common patterns of GM abnormalities in frontal (gyrus rectus), superior temporal, left hippocampal and insular cortex. GM in the left supramarginal gyrus and left middle temporal gyrus were found to be increased in AN-FES but decreased in AT-FES, whereas left median cingulate/paracingulate gyri and right hippocampus GM was decreased in AN-FES but increased in AT-FES. Findings suggest that both AN-FES and AT-FES share frontal, temporal and insular regions as common anatomical regions to be affected indicating these to be the primary regions of GM abnormalities in both groups.

Entities:  

Keywords:  Antipsychotics; first-episode schizophrenia; gray matter; magnetic resonance imaging; meta-analysis; naive

Mesh:

Substances:

Year:  2016        PMID: 27776571     DOI: 10.1017/S0033291716002683

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  19 in total

1.  Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.

Authors:  T Moberget; N T Doan; D Alnæs; T Kaufmann; A Córdova-Palomera; T V Lagerberg; J Diedrichsen; E Schwarz; M Zink; S Eisenacher; P Kirsch; E G Jönsson; H Fatouros-Bergman; L Flyckt; G Pergola; T Quarto; A Bertolino; D Barch; A Meyer-Lindenberg; I Agartz; O A Andreassen; L T Westlye
Journal:  Mol Psychiatry       Date:  2017-05-16       Impact factor: 15.992

2.  Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity.

Authors:  Bo Cao; Raymond Y Cho; Dachun Chen; Meihong Xiu; Li Wang; Jair C Soares; Xiang Yang Zhang
Journal:  Mol Psychiatry       Date:  2018-06-19       Impact factor: 15.992

3.  Facial emotion perception abilities are related to grey matter volume in the culmen of cerebellum anterior lobe in drug-naïve patients with first-episode schizophrenia.

Authors:  Xiaoxin Zhao; Jingjing Yao; Yiding Lv; Xinyue Zhang; Chongyang Han; Lijun Chen; Fangfang Ren; Qun Zhou; Zhuma Jin; Yuan Li; Yasong Du; Yuxiu Sui
Journal:  Brain Imaging Behav       Date:  2022-06-25       Impact factor: 3.224

4.  Effect of Season of Birth on Hippocampus Volume in a Transdiagnostic Sample of Patients With Depression and Schizophrenia.

Authors:  Nora Schaub; Nina Ammann; Frauke Conring; Thomas Müller; Andrea Federspiel; Roland Wiest; Robert Hoepner; Katharina Stegmayer; Sebastian Walther
Journal:  Front Hum Neurosci       Date:  2022-06-13       Impact factor: 3.473

5.  Volumetric Abnormalities in Violent Schizophrenia Patients on the General Psychiatric Ward.

Authors:  FengJu Liu; Yang Shao; Xin Li; Li Liu; Rong Zhao; Bin Xie; Yi Qiao
Journal:  Front Psychiatry       Date:  2020-08-28       Impact factor: 4.157

6.  Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis.

Authors:  Xin Gao; Wenjing Zhang; Li Yao; Yuan Xiao; Lu Liu; Jieke Liu; Siyi Li; Bo Tao; Chandan Shah; Qiyong Gong; John A Sweeney; Su Lui
Journal:  J Psychiatry Neurosci       Date:  2018-03       Impact factor: 6.186

7.  Brain structural correlates of familial risk for mental illness: a meta-analysis of voxel-based morphometry studies in relatives of patients with psychotic or mood disorders.

Authors:  Wenjing Zhang; John A Sweeney; Li Yao; Siyi Li; Jiaxin Zeng; Mengyuan Xu; Maxwell J Tallman; Qiyong Gong; Melissa P DelBello; Su Lui; Fabiano G Nery
Journal:  Neuropsychopharmacology       Date:  2020-04-30       Impact factor: 7.853

8.  Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function.

Authors:  Chunyan Luo; XueNan Pi; Na Hu; Xiao Wang; Yuan Xiao; Siyi Li; John A Sweeney; Jeffrey R Bishop; Qiyong Gong; Dan Xie; Su Lui
Journal:  Mol Psychiatry       Date:  2021-09-29       Impact factor: 15.992

Review 9.  Adolescent Neurodevelopment and Vulnerability to Psychosis.

Authors:  Pooja K Patel; Logan D Leathem; Danielle L Currin; Katherine H Karlsgodt
Journal:  Biol Psychiatry       Date:  2020-07-10       Impact factor: 12.810

10.  Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients.

Authors:  Nian Liu; Yuan Xiao; Wenjing Zhang; Biqiu Tang; Jiaxin Zeng; Na Hu; Shah Chandan; Qiyong Gong; Su Lui
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.